Author

Ratan V. Bhat

Observed names: R Bhat, R V Bhat, R. Bhat, R. V. Bhat, R.V Bhat, R.V. Bhat, Ratan Bhat, Ratan V Bhat

Observed institutions: Mayo Clinic, Johns Hopkins University, University of Colorado Boulder, Washington University in St. Louis, Johns Hopkins Medicine, University of Colorado System, AstraZeneca (Sweden), AstraZeneca (United States), New York University

ORCID: 0000-0002-7374-7039

Observed ORCID: 0000-0002-7374-7039

OpenAlex ID: A5081853343

Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance.

1994 · J S Jung, R V Bhat, et al. · Proceedings of the National Academy of Sciences · 716

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

2005 · Wendy Noble, Emmanuel Planel, et al. · Proceedings of the National Academy of Sciences · 707

PDF

Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418

2003 · Ratan Bhat, Yafeng Xue, et al. · Journal of Biological Chemistry · 553

PDF

Glycogen synthase kinase 3: a drug target for CNS therapies

2004 · Ratan V. Bhat, Samantha L. Budd Haeberlein, et al. · Journal of Neurochemistry · 408

Regulation and localization of tyrosine 216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration

2000 · Ratan V. Bhat, Jason Shanley, et al. · Proceedings of the National Academy of Sciences · 366

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

2004 · Todd D. Gould, Haim Einat, et al. · The International Journal of Neuropsychopharmacology · 314

PDF

Constitutive expression of zif268 in neocortex is regulated by synaptic activity.

1991 · P F Worley, B A Christy, et al. · Proceedings of the National Academy of Sciences · 300

PDF

A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation

2009 · Dominik Paquet, Ratan Bhat, et al. · Journal of Clinical Investigation · 278

GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila

2004 · A Mudher, D Shepherd, et al. · Molecular Psychiatry · 265

D1 Dopamine Receptor Activation of Multiple Transcription Factor Genes in Rat Striatum

1992 · Andrew J. Cole, Ratan V. Bhat, et al. · Journal of Neurochemistry · 188

Increased Expression of IL-1β Converting Enzyme in Hippocampus after Ischemia: Selective Localization in Microglia

1996 · Ratan V. Bhat, Richard DiRocco, et al. · Journal of Neuroscience · 152

PDF

Activation of p38MAPK in Microglia After Ischemia

1998 · Kevin M. Walton, Richard DiRocco, et al. · Journal of Neurochemistry · 150

PDF

Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines

2012 · Stefan Berg, Margareta Bergh, et al. · Journal of Medicinal Chemistry · 149

Glycogen Synthase Kinase-3 Plays a Crucial Role in Tau Exon 10 Splicing and Intranuclear Distribution of SC35

2004 · Félix Hernández, Mar Pérez, et al. · Journal of Biological Chemistry · 135

PDF

Activation of arc, a Putative “Effector” Immediate Early Gene, by Cocaine in Rat Brain

1995 · Jennifer S. Fosnaugh, Ratan V. Bhat, et al. · Journal of Neurochemistry · 132

Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems.

1993 · R V Bhat, J M Baraban · Journal of Pharmacology and Experimental Therapeutics · 132

AZD 1080, a novel GSK 3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans

2013 · Biljana Georgievska, Johan Sandin, et al. · Journal of Neurochemistry · 120

Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil

1998 · Thomas M Engber, Elizabeth J Koury, et al. · Neuroscience Letters · 115

A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinases

2009 · Stéphane Peineau, Céline S Nicolas, et al. · Molecular Brain · 101

PDF

The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?

2018 · Ratan V. Bhat, Ulf Andersson, et al. · Journal of Alzheimer s Disease · 93

GSK3β Signalling: Casting a Wide Net in Alzheimer’s Disease

2002 · Ratan V. Bhat, Samantha L. Budd · Neurosignals · 85

Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice

2001 · Thomas J Gould, Rich A Keith, et al. · Behavioural Brain Research · 80

Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system

1998 · Dorothy G. Flood, James P. Finn, et al. · The Journal of Comparative Neurology · 75

Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists

2007 · Allan C. Collins, Ratan V. Bhat, et al. · Novartis Foundation symposium · 73

Neural-specific expression, genomic structure, and chromosomal localization of the gene encoding the zinc-finger transcription factor NGFI-C.

1992 · S D Crosby, R A Veile, et al. · Proceedings of the National Academy of Sciences · 69

Works count: 60

Citation count: 6,614

H-index: 36

I10-index: 48